Ganglioside Metabolism and Parkinson's Disease.

about

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.GM1 ganglioside prevents axonal regeneration inhibition and cognitive deficits in a mouse model of traumatic brain injury

P2860

Q55392887-C4E834C0-0DCA-4A64-AE3D-BAA8AF73E77C Q58761967-0277D6DB-25C7-4B0E-9A51-C9FE273C5192

P2860

Ganglioside Metabolism and Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q49829715

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Ganglioside Metabolism and Parkinson's Disease.

@en

Ganglioside Metabolism and Parkinson's Disease.

@nl

type

Item

label

Ganglioside Metabolism and Parkinson's Disease.

@en

Ganglioside Metabolism and Parkinson's Disease.

@nl

prefLabel

Ganglioside Metabolism and Parkinson's Disease.

@en

Ganglioside Metabolism and Parkinson's Disease.

@nl

P1476

Ganglioside Metabolism and Parkinson's Disease.

@en

P2860

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects

Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

alpha-Synuclein locus triplication causes Parkinson's disease

Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein

Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNINS.2018.00045

http://www.w3.org/2001/XMLSchema#string

P4011

8f9ea7ee7490f06c7169887bc024a48e0920a4f4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John Forsayeth

Piotr Hadaczek

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29459819

http://www.w3.org/2001/XMLSchema#string

P932

5807391

http://www.w3.org/2001/XMLSchema#string

Ganglioside Metabolism and Parkinson's Disease.

about

P2860

P2860

Ganglioside Metabolism and Parkinson's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P4011

P478

P50

P577

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P4011

P478

P50

P577

P698

P932